<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04318691</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00217-32</org_study_id>
    <nct_id>NCT04318691</nct_id>
  </id_info>
  <brief_title>Netosis in Determination of Respiratory Infection Severity</brief_title>
  <acronym>NETMINDERS</acronym>
  <official_title>Netosis in Mechanically Ventilated ICU Patients in Determination of Respiratory Infection Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate the prognostic value of alveolar and blood NETosis in patients
      under mechanical ventilation and treated for an acute low-respiratory tract infection. The
      main outcome is the occurrence of an acute respiratory distress syndrome (ARDS) according to
      the Berlin definition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neutrophils are the first line of defense against infectious injury. Among the numerous
      mechanisms involving the immune system, neutrophil extracellular traps (NETs) have been
      recently described as an additional way neutrophils are able to use to fight against
      bacteria. NETs are made of DNA and antimicrobial proteins. In the other hand, NETs promote
      coagulation and may contribute to evolution of severe pneumonia into acute respiratory
      distress syndrome.

      The secondary objectives of the study include the research of the relation between blood
      NETosis and alveolar NETosis with:

        -  the documentation of invasive pulmonary infection based on microbiological analysis
           criteria (which would be bacteria or viral) of LBA at admission to ICU;

        -  the diagnosis value of usually used biomarkers: procalcitonin and C-reactive protein;

        -  marbrure score at admission to ICU;

        -  arterial lactatemia;

        -  scores of gravity at admission IGSII and SOFA;

        -  all-cause mortality at day-28;

        -  duration of mechanical ventilation at day-28;

        -  duration of amines at day-28;

        -  developement of hemodynamic failure;

        -  developement of pulmonary circulatory failure.

      The study will include 1) 60 patients under mechanical ventilation admitted to the intensive
      care unit for acute respiratory failure, 2) 10 control patients admitted to the ICU after a
      planned vascular surgery and 3) 10 healthy subjects.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute respiratory distress syndrome occurrence</measure>
    <time_frame>at day-7</time_frame>
    <description>Acute respiratory distress syndrome occurrence according to the Berlin definition within the first 7 days after ICU admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>At day-28</time_frame>
    <description>Vital statue of patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>At day-28</time_frame>
    <description>Duration of mechanical ventilation: number of days without mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGSII score</measure>
    <time_frame>At admission to ICU</time_frame>
    <description>IGSII score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>At admission to ICU</time_frame>
    <description>SOFA score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic failure</measure>
    <time_frame>At day-28</time_frame>
    <description>Development of a hemodynamic failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary circulation failure</measure>
    <time_frame>At day-28</time_frame>
    <description>Development of a pulmonary circulation failure (acute pulmonary heart disease, right ventricle failure)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>acute respiratory failure group</arm_group_label>
    <description>60 patients under mechanical ventilation admitted to the intensive care unit for acute respiratory failure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vascular surgery control group</arm_group_label>
    <description>10 control patients admitted to the ICU after a planned vascular surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers group</arm_group_label>
    <description>10 healthy subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sampling at baseline and at day-3 (10 ml, EDTA tube), test of NETs.</description>
    <arm_group_label>Healthy volunteers group</arm_group_label>
    <arm_group_label>acute respiratory failure group</arm_group_label>
    <arm_group_label>vascular surgery control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bronchoalveolar lavage</intervention_name>
    <description>Bronchoalveolar lavage at admission to the ICU with analysis of cytological, bacteriological, viral and anatomopathological, and test of NETs.</description>
    <arm_group_label>acute respiratory failure group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Adult ICU patients under mechanical ventilation with suspected lower-respiratory tract
             infection;

          -  Adult ICU patients followed vascular surgical intervention;

          -  Healthy Volunteers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        A/ For all subjets:

          -  Be &gt;/= 18 years of age on day of signing informed consent;

          -  Affiliated to the french social security - welfare system in France.

        B/ Inclusion criteria for acute respiratory failure patients:

        admitted to the ICU for acute respiratory failure requiring mechanical ventilation within
        the first 24 hours after admission and suspected to suffer from an infectious pneumonia,
        according to the following criteria:

          -  recent fever;

          -  acute respiratory failure signs (dyspnea, polypnea &gt; 30 cycles/min, hypoxemia PaO2&lt;65
             mmHg);

          -  pulmonary focal signs of auscultation;

          -  evocative signs in chest radiography or chest TDM.

        C/ Inclusion criteria for control patients:

        - admitted to the ICU for post-operative management of vascular surgery.

        Exclusion Criteria:

        A/ For all subjets:

          -  pregnancy,

          -  nosocomial pneumonia,

          -  no social health insurance,

          -  neutropenia of any cause;

          -  patient refusal.

        B/ Exclusion criteria for acute respiratory failure patients:

        - no mechanical ventilation within the first 24 hours after admission to the ICU.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu Godement, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillaume Geri, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Godement, MD</last_name>
    <phone>+33 1 49095603</phone>
    <email>mathieu.godement@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume Geri, MD, PhD</last_name>
    <phone>+33 1 49095601</phone>
    <email>guillaume.geri@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute respiratory distress syndrome</keyword>
  <keyword>adult ICU</keyword>
  <keyword>neutrophil extracellular traps (NETs)</keyword>
  <keyword>Netosis</keyword>
  <keyword>neutrophils</keyword>
  <keyword>mechanical ventilation</keyword>
  <keyword>pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

